|
Variables |
EF+ESV Non- Responders
20 pts |
EF+ESV
Responders
25 pts |
p |
| Age years ± SD |
73 ± 7.1 |
72.3 ± 10.4 |
0.8 |
| Sex male n (%) |
13(65) |
15(60) |
0.7 |
| PM n (%) |
10(50) |
17(68) |
0.2 |
| ICDn (%) |
10(509 |
8(32) |
0.2 |
| Baseline Paced QRS n (%) |
7(35) |
8(32) |
0.8 |
| Permanent AFn (%) |
7(35) |
6(24) |
0.4 |
| ACE or ARBn (%) |
20(100) |
25(100) |
- |
| Betablockersn (%) |
20(100) |
23(92) |
0.2 |
| Diureticsn (%) |
20(100) |
24(96) |
0.4 |
| CADn (%) |
12(60) |
5(20) |
0.006 |
| Prev Ant MIn (%) |
6(30) |
0 |
0.003 |
| QRS durationms ± SD |
186 ± 18.4 |
190 ± 20 |
0.5 |
| LBBB typicaln (%) |
9(45) |
13(52) |
0.6 |
| NYHA n ± SD |
2.6 ± 0.6 |
2.4 ± 0.6 |
0.4 |
| RV apex leadn (%) |
19(95) |
23(92) |
0.7 |
| IV septum mm ± SD |
11.6 ± 3.2 |
11.9 ± 2 |
0.7 |
| Post wallmm ± SD |
11 ± 2.6 |
11.4 ± 1.9 |
0.5 |
| EDV pre ml/m2 ± SD |
109.5 ± 45 |
120.3 ± 36 |
0.4 |
| EDD premm ± SD |
67.3 ± 7.6 |
65.3 ± 8 |
0.4 |
| ESV preml/m2 ± SD |
75.4 ± 36 |
82.4 ± 29 |
0.5 |
| LVEF pre % ± SD |
32.1 ± 6.3 |
32.5 ± 8.3 |
0.9 |
| MR /4 n ± SD |
1.9 ± 1.2 |
1.5 ± 0.9 |
0.2 |
| TR /4n ± SD |
1.3 ± 1 |
1 ± 0.8 |
0.3 |
| Follow up months ± SD |
10 ± 6.8 |
14 ± 8.3 |
0.09 |
| LAO ILDcm/m2 ± SD |
4.4 ± 1.8 |
4.3 ± 1.2 |
0.9 |
| RAO ILD cm/m2 ± SD |
3.9 ± 1.6 |
3.6 ± 1.5 |
0.5 |
| RAO-LAO index cm/m2 ± SD |
37.1 ± 17.1 |
34.8 ± 18 |
0.6 |
|
